Erratum to: Engagement with a digital therapeutic for smoking cessation designed for persons with psychiatric illness fully mediates smoking outcomes in a pilot randomized controlled trial

Abstract Objective Morbidity and mortality from smoking-related diseases among people living with HIV (PLWH) in the U.S. surpasses that due to HIV itself. Conventional smoking cessation treatments have not demonstrated strong efficacy among PLWH. We conducted a pilot randomized controlled trial (RCT) to evaluate a tailored smoking cessation intervention based on the minority stress model. We compared standard of care counseling (SOC) to a tailored intervention (TI) including one face-to-face counseling session incorporating cognitive behavioral therapy to build resilience, and 30 days of 2-way text messaging. Results The primary outcome was smoking cessation. Secondary outcomes included cigarettes per day (CPD), exhaled carbon monoxide (CO), and cessation self-efficacy. A total of 25 participants were enrolled (TI:11, SOC:14), and 2 were lost to follow-up. There were no significant differences in quit rates between study groups. However, there was a significantly greater decrease in CPD in the TI versus SOC (13.5 vs. 0.0, p-value:0.036). Additionally, self-efficacy increased in both groups (TI p-value:0.012, SOC p-value:0.049) and CO decreased in both groups (TI p-value: < 0.001, SOC p-value:0.049). This intervention shows promise to support smoking cessation among PLWH. A larger study is needed to fully evaluate the efficacy of this approach. Clinical trial: Trial Registration: Retrospectively registered (10/20/2020) NCT04594109.

Download Full-text

Adaptation and assessment of a text messaging smoking cessation intervention in Viet Nam: A pilot randomized controlled trial (Preprint)

JMIR mhealth and uhealth ◽

10.2196/27478 ◽

2021 ◽

Author(s):

Nan Jiang ◽

Nam Nguyen ◽

Nina Siman ◽

Charles M. Cleland ◽

Trang Nguyen ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Smoking Cessation ◽

Text Messaging ◽

Controlled Trial ◽

Smoking Cessation Intervention ◽

Viet Nam ◽

Randomized Controlled ◽

Cessation Intervention ◽

Pilot Randomized Controlled Trial

Download Full-text

Pilot Randomized Controlled Trial of a Novel Smoking Cessation App Designed for Individuals With Co-Occurring Tobacco Use Disorder and Serious Mental Illness

Nicotine & Tobacco Research ◽

10.1093/ntr/ntz202 ◽

2019 ◽

Vol 22 (9) ◽

pp. 1533-1542 ◽

Cited By ~ 2

Author(s):

Roger Vilardaga ◽

Javier Rizo ◽

Paige E Palenski ◽

Paolo Mannelli ◽

Jason A Oliver ◽

...

Keyword(s):

Mental Illness ◽

Randomized Controlled Trial ◽

Smoking Cessation ◽

Tobacco Use ◽

Controlled Trial ◽

Smoking Cessation Treatment ◽

Tobacco Use Disorder ◽

Randomized Controlled ◽

Cessation Treatment ◽

Pilot Randomized Controlled Trial

Abstract Introduction High rates of tobacco use among people with serious mental illness (SMI), along with their unique needs, suggest the importance of developing tailored smoking cessation interventions for this group. Previous early-phase work empirically validated the design and content of Learn to Quit, a theory-based app designed for this population. Methods In a pilot randomized controlled trial, we compared the feasibility, acceptability, and preliminary efficacy of Learn to Quit versus QuitGuide, an app designed for the general population. All participants received nicotine replacement therapy and technical assistance. Daily smokers with SMI (N = 62) participated in the trial with outcomes assessed at weeks 4, 8, 12, and 16. Results Compared to QuitGuide, Learn to Quit participants had similar number of days of app use (34 vs. 32, p = .754), but larger number of app interactions (335 vs. 205; p = .001), longer durations of app use (4.24 hrs. vs. 2.14 hrs; p = .044), and higher usability scores (85 vs. 79, p = .046). At week 16, Learn to Quit led to greater reductions in cigarettes per day (12.3 vs. 5.9 for QuitGuide; p = 0.10). Thirty-day point prevalence abstinence was verified in 12% of Learn to Quit participants versus 3% of QuitGuide participants (odds ratio = 3.86, confidence interval = 0.41 to 36, p = .239). Changes in psychiatric symptoms and adverse events were not clinically significant between conditions. Conclusions This pilot trial provides strong evidence of Learn to Quit’s usability, feasibility, and safety. Preliminary evidence suggests the app may be efficacious. A randomized controlled efficacy trial is needed to test the app in a larger sample of smokers with SMI. Implications This study suggests that the Learn to Quit app is a feasible approach to deliver smoking cessation treatment in patients with co-occurring tobacco use disorder and SMI. This means that, if found efficacious, this technology could be used to deploy smoking cessation treatment to larger segments of this population, hence improving public health. Therefore, a randomized controlled trial should be conducted to examine the efficacy of this digital intervention.

Download Full-text

Auricular Acupressure for Smoking Cessation: A Pilot Randomized Controlled Trial

Medical Acupuncture ◽

10.1089/acu.2010.0763 ◽

2010 ◽

Vol 22 (4) ◽

pp. 265-271 ◽

Cited By ~ 6

Author(s):

Yun-Kwok Wing ◽

Anna Lee ◽

Eliza L.Y. Wong ◽

Ping-chung Leung ◽

Lang Zhang ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Smoking Cessation ◽

Controlled Trial ◽

Randomized Controlled ◽

Auricular Acupressure ◽

Pilot Randomized Controlled Trial

Download Full-text

A Pilot Randomized Controlled Trial of Distress Tolerance Treatment for Weight Concern in Smoking Cessation Among Women

Nicotine & Tobacco Research ◽

10.1093/ntr/ntaa026 ◽

2020 ◽

Vol 22 (9) ◽

pp. 1578-1586

Author(s):

Erika Litvin Bloom ◽

Susan E Ramsey ◽

Ana M Abrantes ◽

Laura Hunt ◽

Rena R Wing ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Smoking Cessation ◽

Weight Gain ◽

Emotional Eating ◽

Distress Tolerance ◽

Controlled Trial ◽

Randomized Controlled ◽

Group Sessions ◽

Pilot Randomized Controlled Trial

Abstract Introduction The majority of women who smoke cigarettes report that concern about weight gain is a barrier to quitting. We developed an intervention incorporating distress tolerance, appetite awareness, and mindful eating skills to target concerns about post-cessation weight gain and emotional eating (DT-W). In the current study, we conducted a pilot randomized controlled trial of DT-W versus a smoking health education (HE) intervention. Methods Participants (N = 69 adult female, weight-concerned smokers) were recruited in cohorts of 4–11. Cohorts were randomized to DT-W or HE. DT-W and HE were matched on format (single individual session followed by eight group sessions), inclusion of cognitive behavioral therapy for smoking cessation (CBT) content, and pharmacotherapy (nicotine patches). Follow-up assessments occurred at 1-, 3-, and 6-months post-treatment. Results The recruitment goal was met; 61 of the 69 participants attended at least one group session. There were no significant differences between DT-W and HE in the number of group sessions attended (DT-W adjusted M = 5.09, HE adjusted M = 5.03, p = .92), ratings of treatment effectiveness or usefulness of skills, or retention at 6-month follow-up (79% in DT-W vs. 78% in HE) (ps > .05), but comprehension ratings were lower in DT-W than in HE (p = .02). Conclusions Overall, these results suggest that the study procedures and interventions were feasible and acceptable, but changes to the DT-W intervention content to improve comprehension should be considered prior to conducting a fully powered trial. Implications A distress tolerance-based treatment targeting fear of weight gain after smoking cessation and post-cessation emotional eating was feasible and acceptable relative to a smoking HE comparison condition, but changes should be considered before conducting a larger trial. Continued innovation in treatment development for weight-concerned smokers is needed.

Download Full-text